Atom Investors LP Pulmonx Corp Transaction History

Atom Investors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$2.57 - $6.87 $5,589 - $14,942	2,175 Added 13.58%	18,191 $47,000
Q1 2025 May 15, 2025	SELL	$5.68 - $9.22 $14,773 - $23,981	-2,601 Reduced 13.97%	16,016 $107,000
Q4 2024 Feb 14, 2025	SELL	$5.93 - $7.71 $4,577 - $5,952	-772 Reduced 3.98%	18,617 $126,000
Q3 2024 Nov 14, 2024	SELL	$5.59 - $8.58 $515,984 - $791,976	-92,305 Reduced 82.64%	19,389 $160,000
Q2 2024 Aug 14, 2024	BUY	$5.77 - $9.82 $644,474 - $1.1 Million	111,694 New	111,694 $708,000

114

31.3M

20.7K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $55.5M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.